These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28948565)

  • 1. Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients.
    Sulik-Tyszka B; Snarski E; Niedźwiedzka M; Augustyniak M; Myhre TN; Kacprzyk A; Swoboda-Kopeć E; Roszkowska M; Dwilewicz-Trojaczek J; Jędrzejczak WW; Wróblewska M
    Probiotics Antimicrob Proteins; 2018 Jun; 10(2):350-355. PubMed ID: 28948565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Saccharomyces cerevisiae fungemia in hospitalised patients administered Saccharomyces boulardii probiotic.
    Wombwell E; Bransteitter B; Gillen LR
    Mycoses; 2021 Dec; 64(12):1521-1526. PubMed ID: 34585799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers.
    Kabbani TA; Pallav K; Dowd SE; Villafuerte-Galvez J; Vanga RR; Castillo NE; Hansen J; Dennis M; Leffler DA; Kelly CP
    Gut Microbes; 2017 Jan; 8(1):17-32. PubMed ID: 27973989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic yeast Saccharomyces boulardii (nom. nud.) modulates adhesive properties of Candida glabrata.
    Tomičić Z; Zupan J; Matos T; Raspor P
    Med Mycol; 2016 Nov; 54(8):835-45. PubMed ID: 27250926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Clinical Trial: Impact of Oral Administration of Saccharomyces boulardii on Gene Expression of Intestinal Cytokines in Patients Undergoing Colon Resection.
    Consoli ML; da Silva RS; Nicoli JR; Bruña-Romero O; da Silva RG; de Vasconcelos Generoso S; Correia MI
    JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1114-1121. PubMed ID: 25917895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saccharomyces boulardii and Candida albicans experimental colonization of the murine gut.
    Samonis G; Falagas ME; Lionakis S; Ntaoukakis M; Kofteridis DP; Ntalas I; Maraki S
    Med Mycol; 2011 May; 49(4):395-9. PubMed ID: 21077734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of culture conditions on co-aggregation of probiotic yeast Saccharomyces boulardii with Candida spp. and their auto-aggregation.
    Tomičić R; Tomičić Z; Raspor P
    Folia Microbiol (Praha); 2022 Jun; 67(3):507-515. PubMed ID: 35169980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saccharomyces cerevisiae fungemia: Risk factors, outcome and links with S. boulardii-containing probiotic administration.
    Poncelet A; Ruelle L; Konopnicki D; Miendje Deyi VY; Dauby N
    Infect Dis Now; 2021 May; 51(3):293-295. PubMed ID: 33934809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of probiotic Saccharomyces boulardii in experimental giardiasis.
    Ribeiro MRS; Oliveira DR; Oliveira FMS; Caliari MV; Martins FS; Nicoli JR; Torres MF; Andrade MER; Cardoso VN; Gomes MA
    Benef Microbes; 2018 Sep; 9(5):789-797. PubMed ID: 30165752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract.
    Hedin KA; Rees VE; Zhang H; Kruse V; Vazquez-Uribe R; Sommer MOA
    Sci Rep; 2022 May; 12(1):8862. PubMed ID: 35614092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Efficacy Comparison of Saccharomyces Boulardii and Lactic Acid as Probiotics in Acute Pediatric Diarrhea.
    Asmat S; Shaukat F; Asmat R; Bakhat HFSG; Asmat TM
    J Coll Physicians Surg Pak; 2018 Mar; 28(3):214-217. PubMed ID: 29544579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Saccharomyces boulardii CNCM I-745 - the medicinal yeast improves intestinal enzyme function].
    Moré MI
    MMW Fortschr Med; 2019 Mar; 161(Suppl 4):20-24. PubMed ID: 30895510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient.
    Landaburu MF; López Daneri GA; Relloso S; Zarlenga LJ; Vinante MA; Mujica MT
    Rev Argent Microbiol; 2020; 52(1):27-30. PubMed ID: 31262611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of anti-Helicobacter pylori concomitant therapy and probiotic supplementation on the throat and gut microbiota in humans.
    Wang ZJ; Chen XF; Zhang ZX; Li YC; Deng J; Tu J; Song ZQ; Zou QH
    Microb Pathog; 2017 Aug; 109():156-161. PubMed ID: 28552806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Saccharomyces fungemia: A systematic review.
    Vinayagamoorthy K; Pentapati KC; Prakash H
    Med Mycol; 2023 Feb; 61(2):. PubMed ID: 36806741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Saccharomyces cerevisiae var. boulardii in food processing: a review.
    Lazo-Vélez MA; Serna-Saldívar SO; Rosales-Medina MF; Tinoco-Alvear M; Briones-García M
    J Appl Microbiol; 2018 Oct; 125(4):943-951. PubMed ID: 29961970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic's use.
    Martin IW; Tonner R; Trivedi J; Miller H; Lee R; Liang X; Rotello L; Isenbergh E; Anderson J; Perl T; Zhang SX
    Diagn Microbiol Infect Dis; 2017 Mar; 87(3):286-288. PubMed ID: 28024866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A multicenter randomized controlled study of
    Wan CM; Yu H; Liu G; Xu HM; Mao ZQ; Xu Y; Jin Y; Luo RP; Wang WJ; Fang F
    Zhonghua Er Ke Za Zhi; 2017 May; 55(5):349-354. PubMed ID: 28482385
    [No Abstract]   [Full Text] [Related]  

  • 19.
    Durmusoglu D; Al'Abri IS; Collins SP; Cheng J; Eroglu A; Beisel CL; Crook N
    ACS Synth Biol; 2021 May; 10(5):1039-1052. PubMed ID: 33843197
    [No Abstract]   [Full Text] [Related]  

  • 20. Aging Eye Microbiota in Dry Eye Syndrome in Patients Treated with
    Chisari G; Chisari EM; Borzi AM; Chisari CG
    Curr Clin Pharmacol; 2017; 12(2):99-105. PubMed ID: 28676009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.